As of 2025-09-17, the Relative Valuation of Britannia Life Sciences Inc (BLAB.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 CAD, the upside of Britannia Life Sciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-09-03 | -1.32 |
| 2025-09-02 | -1.63 |
| 2025-08-28 | -1.42 |
| 2025-08-26 | -1.42 |
| 2025-08-22 | -1.42 |
| 2025-08-21 | -1.42 |
| 2025-08-20 | -1.63 |
| 2025-08-18 | -1.73 |
| 2025-08-15 | -1.42 |
| 2025-08-14 | -1.32 |
| 2025-08-13 | -1.53 |
| 2025-08-12 | -1.73 |
| 2025-08-11 | -1.63 |
| 2025-08-06 | -1.63 |
| 2025-08-05 | -1.83 |
| 2025-07-31 | -1.83 |
| 2025-07-30 | -1.83 |
| 2025-07-29 | -1.93 |
| 2025-07-28 | -2.03 |
| 2025-07-25 | -2.03 |
| 2025-07-24 | -1.83 |
| 2025-07-23 | -1.83 |
| 2025-07-22 | -1.73 |
| 2025-07-17 | -1.32 |
| 2025-07-16 | -1.42 |
| 2025-07-14 | -1.22 |
| 2025-07-09 | -1.42 |
| 2025-07-04 | -1.42 |
| 2025-07-03 | -1.22 |
| 2025-06-26 | -1.22 |
| 2025-06-20 | -1.32 |